Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma.
- DOI
- 10.1021/acs.jmedchem.5c02575
- Published
- 2026 Jan 8
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.5c02575,
title = {Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma.},
author = {Leng L and He S and Zhang M and Yang Y and Ge Y and Yuan Y and Niu Q and Shi X and Chen Z and Zhao Z and He H and Li H and Xu Y and Wang Z and Li S},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.5c02575},
url = {https://doi.org/10.1021/acs.jmedchem.5c02575}
}RIS
TY - JOUR TI - Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma. AU - Leng L AU - He S AU - Zhang M AU - Yang Y AU - Ge Y AU - Yuan Y AU - Niu Q AU - Shi X AU - Chen Z AU - Zhao Z AU - He H AU - Li H AU - Xu Y AU - Wang Z AU - Li S PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.5c02575 UR - https://doi.org/10.1021/acs.jmedchem.5c02575 ER -
APA
L, L., S, H., M, Z., Y, Y., Y, G., Y, Y., Q, N., X, S., Z, C., Z, Z., H, H., H, L., Y, X., Z, W., & S, L. (2026). Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.5c02575
Source records
- pubmed · retrieved 2026-09-26T09:23:25.072Z